As aging bodies decline, the brain loses the ability to cleanse itself of waste, a scenario that scientists think could be contributing to neurodegenerative conditions such as Alzheimer's disease and ...

ALZcure is pioneering blockchain-powered funding for Alzheimer's research through Decentralized Science (DeSci). Built on ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

Samuel Simon will tell you he has always been a troublemaker. As he speaks it becomes obvious he means an activist, or as he says, “a troublemaker who wants to ...

The world is ageing quickly. People older than 64 years already outnumber children younger than five, and this asymmetry will continue to widen. As life expectancy increases and fertility rates ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Their risk of getting it increases with each decade after 40, and their overall lifetime risk is more than 90%.

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.